| A Tale of Two Markets for AIDS Vaccine (Developed vs. Developing World) | January 28, 2004 |
Dr. Don Francis
|
Vaxgen |
Entrepreneurial Thought Leader Speaker Series |
| Views: 699 |
|
| Video 3 of 10 from this talk |
- 02:39Don Francis's Mission - Kids and Kids' Health
- 08:54Vaccines Have a Social Problem!
- 05:42A Tale of Two Markets for AIDS Vaccine (Developed vs. Developing World)
- 05:00The Vaxgen Story
- 01:59Bush and 9/11 Put AIDS on the Back Burner - And a New Social Venture is Born
- 01:53Intellectual Property Issues Between Vaxgen and the New Social Venture
- 01:40Non-profit vs. Free Market: The Gates Foundation Changes the Game
- 00:59Is HIV Vaccine Possible?
- 03:15Career Advice: Follow Your Passion and Come to the Bay Area!
- 03:30Alliances and Collaboration
Description
The major market for the AIDS vaccine is in the developing world, says Francis, but there is significant demand in the United States with 40,000 new cases a year. There are a lot of unknowns in the business climate in the United States affecting the profitability of a vaccine. It is difficult to encourage investment when a blockbuster drugs would have a much higher rate of return, he adds.
Comments 
Related Videos:
